| Primary |
| Hypertension |
45.7% |
| Spinal Column Stenosis |
4.5% |
| Diabetes Mellitus |
4.3% |
| Renovascular Hypertension |
4.1% |
| Depression |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Essential Hypertension |
3.4% |
| Acute Myocardial Infarction |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Hyperuricaemia |
3.2% |
| Cardiovascular Disorder |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Pemphigus |
2.7% |
| Hypercholesterolaemia |
2.5% |
| Diabetic Nephropathy |
2.0% |
| Schizoaffective Disorder |
1.8% |
| Atrial Fibrillation |
1.6% |
| Cardiac Failure |
1.6% |
| Hyperlipidaemia |
1.6% |
| Pain |
1.4% |
|
| Renal Failure Acute |
12.9% |
| Hyponatraemia |
11.8% |
| Colitis |
7.1% |
| Loss Of Consciousness |
7.1% |
| Hypoglycaemia |
5.9% |
| Syncope |
5.9% |
| Hyperkalaemia |
4.7% |
| Pemphigus |
4.7% |
| Urinary Tract Infection |
4.7% |
| Weight Decreased |
4.7% |
| Cardiac Disorder |
3.5% |
| Hyperbilirubinaemia |
3.5% |
| Hypertension |
3.5% |
| Multi-organ Failure |
3.5% |
| Stevens-johnson Syndrome |
3.5% |
| Vomiting |
3.5% |
| Arrhythmia |
2.4% |
| Completed Suicide |
2.4% |
| Confusional State |
2.4% |
| Dehydration |
2.4% |
|
| Secondary |
| Hypertension |
32.0% |
| Product Used For Unknown Indication |
19.4% |
| Drug Use For Unknown Indication |
6.3% |
| Rheumatoid Arthritis |
5.9% |
| Depression |
5.6% |
| Diabetes Mellitus |
4.3% |
| Renovascular Hypertension |
4.2% |
| Type 2 Diabetes Mellitus |
3.8% |
| Rheumatoid Vasculitis |
2.2% |
| Hypercholesterolaemia |
2.1% |
| Osteoporosis Prophylaxis |
2.1% |
| Prophylaxis |
1.8% |
| Myocardial Infarction |
1.7% |
| Essential Hypertension |
1.5% |
| Pain |
1.5% |
| Atrial Fibrillation |
1.4% |
| Cardiovascular Disorder |
1.4% |
| Reflux Oesophagitis |
1.1% |
| Gastritis Prophylaxis |
0.8% |
| Hyperlipidaemia |
0.8% |
|
| Weight Loss Poor |
22.0% |
| Hyponatraemia |
8.3% |
| Syncope |
5.5% |
| Torsade De Pointes |
5.5% |
| Urinary Tract Infection |
5.5% |
| Angioedema |
4.6% |
| Hepatic Enzyme Increased |
4.6% |
| Hypoglycaemia |
4.6% |
| Renal Failure Acute |
4.6% |
| Death |
3.7% |
| Hypoparathyroidism |
3.7% |
| Rash Erythematous |
3.7% |
| Renal Failure |
3.7% |
| Weight Decreased |
3.7% |
| General Physical Health Deterioration |
2.8% |
| Liver Disorder |
2.8% |
| Pancytopenia |
2.8% |
| Rhabdomyolysis |
2.8% |
| Suicide Attempt |
2.8% |
| Toxic Skin Eruption |
2.8% |
|
| Concomitant |
| Hypertension |
24.4% |
| Drug Use For Unknown Indication |
19.8% |
| Product Used For Unknown Indication |
15.7% |
| Rheumatoid Arthritis |
7.6% |
| Prophylaxis |
5.2% |
| Diabetes Mellitus |
4.7% |
| Type 2 Diabetes Mellitus |
4.2% |
| Gastric Ulcer |
1.8% |
| Hepatitis C |
1.8% |
| Depression |
1.7% |
| Psoriasis |
1.6% |
| Atrial Fibrillation |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Hyperlipidaemia |
1.3% |
| Multiple Myeloma |
1.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.3% |
| Diarrhoea |
1.3% |
| Pain |
1.1% |
| Constipation |
1.1% |
| Antibiotic Prophylaxis |
1.0% |
|
| Vomiting |
11.8% |
| Hyponatraemia |
6.4% |
| Pyrexia |
6.4% |
| Rash |
6.4% |
| Syncope |
5.7% |
| Death |
5.4% |
| Renal Failure Acute |
5.4% |
| Urticaria |
5.4% |
| Renal Failure |
4.6% |
| Rhabdomyolysis |
4.6% |
| Diarrhoea |
4.3% |
| Flushing |
3.9% |
| Left Ventricular Dysfunction |
3.9% |
| Pruritus |
3.9% |
| Urinary Tract Infection |
3.9% |
| Weight Increased |
3.9% |
| Loss Of Consciousness |
3.6% |
| Pulmonary Embolism |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Atrial Fibrillation |
3.2% |
|
| Interacting |
| Atrial Fibrillation |
22.2% |
| Cardiac Failure |
22.2% |
| Hypertension |
22.2% |
| Prophylaxis |
22.2% |
| Back Pain |
5.6% |
| Product Used For Unknown Indication |
5.6% |
|
| Blood Pressure Abnormal |
25.0% |
| Multi-organ Failure |
25.0% |
| Renal Failure Acute |
25.0% |
| Toxicity To Various Agents |
25.0% |
|
